Lansoprazole Liconsa 15 mg hard gastro-resist. caps.

Pajjiż: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Lansoprazole 15 mg

Disponibbli minn:

Laboratorios Liconsa S.A.

Kodiċi ATC:

A02BC03

INN (Isem Internazzjonali):

Lansoprazole

Dożaġġ:

15 mg

Għamla farmaċewtika:

Gastro-resistant capsule, hard

Kompożizzjoni:

Lansoprazole 15 mg

Rotta amministrattiva:

Oral use

Żona terapewtika:

Lansoprazole

Sommarju tal-prodott:

CTI code: 445243-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445243-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445243-05 - Pack size: 84 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445243-06 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445243-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445243-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445243-07 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445234-07 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445234-06 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445234-05 - Pack size: 84 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445234-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445234-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445234-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445234-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: No

Data ta 'l-awtorizzazzjoni:

2013-11-22